Depreciation of Phathom Pharmaceuticals, Inc. from 31 Dec 2018 to 30 Sep 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Phathom Pharmaceuticals, Inc. quarterly and annual Depreciation in USD history and change rate from 31 Dec 2018 to 30 Sep 2023.
  • Phathom Pharmaceuticals, Inc. Depreciation for the quarter ending 30 Sep 2023 was $100,000, a 50% decline year-over-year.
  • Phathom Pharmaceuticals, Inc. Depreciation for the twelve months ending 30 Sep 2023 was $500,000, a 2.7% decline year-over-year.
  • Phathom Pharmaceuticals, Inc. annual Depreciation for 2022 was $600,000, a 20% increase from 2021.
  • Phathom Pharmaceuticals, Inc. annual Depreciation for 2021 was $500,000, a 67% increase from 2020.
  • Phathom Pharmaceuticals, Inc. annual Depreciation for 2020 was $300,000, a 3650% increase from 2019.
Source SEC data
View on sec.gov
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

Phathom Pharmaceuticals, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2023 $500,000 $100,000 -$100,000 -50% 01 Jul 2023 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 $600,000 $100,000 $0 0% 01 Apr 2023 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 $600,000 $100,000 $0 0% 01 Jan 2023 31 Mar 2023 10-Q 10 May 2023 2023 Q1
Q4 2022 $600,000 $200,000 +$86,000 +75% 01 Oct 2022 31 Dec 2022 10-K 28 Feb 2023 2022 FY
Q3 2022 $514,000 $200,000 +$70,000 +54% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023 2023 Q3
Q2 2022 $444,000 $100,000 -$31,000 -24% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023 2023 Q2
Q1 2022 $475,000 $100,000 -$25,000 -20% 01 Jan 2022 31 Mar 2022 10-Q 10 May 2023 2023 Q1
Q4 2021 $500,000 $114,000 +$31,000 +37% 01 Oct 2021 31 Dec 2021 10-K 28 Feb 2023 2022 FY
Q3 2021 $469,000 $130,000 +$42,000 +48% 01 Jul 2021 30 Sep 2021 10-Q/A 09 Nov 2022 2022 Q3
Q2 2021 $427,000 $131,000 +$54,000 +70% 01 Apr 2021 30 Jun 2021 10-Q 02 Aug 2022 2022 Q2
Q1 2021 $373,000 $125,000 +$73,000 +140% 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022 2022 Q1
Q4 2020 $300,000 $83,000 01 Oct 2020 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q3 2020 $88,000 +$86,000 +4300% 01 Jul 2020 30 Sep 2020 10-Q 08 Nov 2021 2021 Q3
Q2 2020 $77,000 01 Apr 2020 30 Jun 2020 10-Q 10 Aug 2021 2021 Q2
Q1 2020 $52,000 +$52,000 01 Jan 2020 31 Mar 2020 10-Q 11 May 2021 2021 Q1
Q3 2019 $2,000 01 Jul 2019 30 Sep 2019 10-Q 10 Nov 2020 2020 Q3
Q1 2019 $0 01 Jan 2019 31 Mar 2019 10-Q 12 May 2020 2020 Q1

Phathom Pharmaceuticals, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2022 $600,000 +$100,000 +20% 01 Jan 2022 31 Dec 2022 10-K 28 Feb 2023 2022 FY
2021 $500,000 +$200,000 +67% 01 Jan 2021 31 Dec 2021 10-K 28 Feb 2023 2022 FY
2020 $300,000 +$292,000 +3650% 01 Jan 2020 31 Dec 2020 10-K 01 Mar 2022 2021 FY
2019 $8,000 +$8,000 01 Jan 2019 31 Dec 2019 10-K 30 Mar 2021 2020 FY
2018 $0 01 Jan 2018 31 Dec 2018 10-K 19 Mar 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.